INS and diabetes mellitus: Ninety-two percent (n = 22) reported that they spent less time managing their diabetes with the closed-loop system than in the control period, and 87% (n = 21) were less worried about their glucose levels with the closed-loop system than with standard insulin therapy (Supplementary Table 4).